Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (NCT07197996) titled 'The RETRAIN Trial Phase 2' on Sept. 25.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: None (Open Label).
Primary Sponsor: Firstkind Ltd
Condition:
Ischaemic Stroke
Intervention:
Device: Intermittent Pneumatic Compression
Recruitment Status: Recruiting
Phase: N/A
Date of First Enrollment: July 1, 2025
Target Sample Size: 80
Countries of Recruitment:
United Kingdom
To know more, visit https://clinicaltrials.gov/study/NCT07197996
Published by HT Digital Content Services with permission from Health Daily Dige...